Virus Protease

all Inhibitors (179)

CAS No.	Product Name	Inquiry
791838-63-6	Denv-IN-9
81-55-0	1,8-Dihydroxy-4,5-dinitroanthraquinone 1,8-Dihydroxy-4,5-dinitroanthraquinone is an NS2B-NS3 protease-specific inhibitor used in the treatment of dengue fever and West Nile virus infections.
84-54-8	Tectoquinone 2-Methylanthraquinone is extracted from the roots of Morinda umbellata L. It shows the strongest mosquito larvicidal activity. It is a component of a potential biomarker and may be used to prepare bioreducible anthraquinone derivatives.
84-65-1	Anthraquinone Anthraquinone is used in dye manufacturing, the textile and pulp industries, and as a bird repellant.
856242-63-2	MPI8
884650-98-0	Mpro inhibitor N3
909859-19-4	SID-852843
910582-16-0	ZIKV-IN-2 ZIKV-IN-2 (compound 3a) is a potent ZIKV NS5 methyl transferase (MTase) inhibitor with an IC50 value of 38.86 μM. ZIKV-IN-2 inhibits ZIKV replication and infection. ZIKV-IN-2 can be used in research of Zika virus (ZIKV).
921943-73-9	Acetylsalicylic Acid-[d3] Acetylsalicylic Acid-[d3] is the labelled analogue of Acetylsalicylic Acid, which is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pains and inflammations.
940908-79-2	Mericitabine R-7128 is a selective nucleoside analog inhibitor of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase, with activity across all HCV genotypes. It is a nucleoside polymerase inhibitor (NPI) and is able to inhibit the RNA synthesis of HCV in vitro.
947303-87-9	PF-429242 PF 429242 is a reversible, competitive, cell permeable inhibitor of sterol regulatory element-binding protein (SREBP) site 1 protease (IC50 = 0.175 μM) without disrupting a panel of serine proteases. Some studies reported that the inhibition of SKI-1/S1P, a master lipo- 387 genic regulator, could impair HCV genome replication, lipid droplet 388 homeostasis and the production of infectious HCV virions.
947699-46-9	ZIKV-IN-3 ZIKV-IN-3 (compound 5a), an andrographolide derivatives, is a potent ZIKV NS5 methyl transferase (MTase) inhibitor with an IC50 value of 18.34 μM. ZIKV-IN-3 inhibits ZIKV replication and infection. ZIKV-IN-3 can be used in research of Zika virus (ZIKV).
96-50-4	2-Aminothiazole Aminothiazole can be used as a thyroid inhibitor and it has antibacterial activity.
97781-16-3	Acetylsalicylic Acid-[d4] Acetylsalicylic Acid-[d4] is the labelled analogue of Acetylsalicylic Acid, which is an antithrombotic, anti-inflammatory, antipyretic analgesic. Acetylsalicylic Acid is an inhibitor of Cox-1 and Cox-2.
98-98-6	2-Picolinic acid Picolinic acid is a metabolite of tryptophan that acts as an anti-infective and immunomodulator. It is produced under inflammatory conditions.
570390-00-0	A2ti-1 A2ti-1 is a selective and high-affinity inhibitor of annexin A2/S100A10 heterotetramer (A2t) with an IC50 of 24 μM. A2ti-1 specifically disrupts the protein-protein interaction (PPI) between A2 and S100A10. It protects against human papillomavirus type 16 (HPV16) infection.
103476-89-7	Leupeptin hemisulfate Leupeptin Hemisulfate is a reversible inhibitor of serine and cysteine proteases. It can be used in skincare products to help reduce inflammation and provide soothing effects to the skin.
905586-69-8	AZ-960 AZ-960 is an ATP-competitive inhibitor of JAK2 with Ki value of 0.45 nM. It inhibits proliferation in a SET-2 human megakaryoblastic cell line harboring the JAK2V617F mutation with GI50 value of 33 nM.
2248666-66-0	PF 429242 dihydrochloride PF 429242 is a reversible and competitive inhibitor of sterol regulatory element-binding protein (SREBP) site 1 protease (IC50 = 0.175 μM), a transcriptional regulators of cholesterol, fatty acid, and glucose metabolism. It reduces hepatic synthesis of cholesterol and fatty acid in mice.
482646-13-9	A2ti-2 A2ti-2 is a selective and low-affinity inhibitor of annexin A2/S100A10 heterotetramer (A2t) with an IC50 of 230 μM. A2ti-2 specifically disrupts the protein-protein interaction (PPI) between A2 and S100A10. It protects against human papillomavirus type 16 (HPV16) infection.

Viral proteases are enzymes encoded by the genetic material (DNA or RNA) of viral pathogens that catalyze the cleavage of specific peptide bonds in viral polyprotein precursors or in cellular proteins. different catalytic mechanisms are used by viral proteases which include srine, cysteine or aspartic acid residues to attack the cleaved peptide bond. The initial spike protein priming by transmembrane protease, serine 2 (TMPRSS2), is critical for entry of SARS-CoV-2. Furthermore, the success of anti-HIV-1 therapy using specific protease inhibitors suggests that viral proteases can be effective molecular targets for the development of other antiviral drugs.

Proteases play multiple roles in health and disease, and researchers have expressed great interest in the design and development of inhibitors of the synthesis of disease-related proteases. Virus-encoded proteases have been shown to be involved in the replication of many viruses.

※ Please kindly note that our services are for research use only.